Morepen Laboratories (NSE:MOREPENLAB) Forward Dividend Yield %: 0.38% (As of Jun. 27, 2026)


NSE:MOREPENLAB Morepen Laboratories Ltd NSE:MOREPENLAB
74 GF Score
Price ₹53.16
GF Value ₹49.82
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Morepen Laboratories Forward Dividend Yield %?

Morepen Laboratories NSE:MOREPENLAB +2.00% 74 Forward Dividend Yield % is 0.38% as of Jun. 27, 2026. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 74/100 and a GF Value™ of ₹49.82 (Fairly Valued). The stock has 5 warning signs investors should review. Among 504 Drug Manufacturers companies, Morepen Laboratories ranks worse than 87.3% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of Morepen Laboratories is 0.38%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of Morepen Laboratories is 0.38%.

NSE:MOREPENLAB's Forward Dividend Yield % is ranked worse than
87.3% of 504 companies
in the Drug Manufacturers industry
Industry Median: 2.08 vs NSE:MOREPENLAB: 0.38

Morepen Laboratories's Dividends per Share for the three months ended in Mar. 2026 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Morepen Laboratories  (NSE:MOREPENLAB) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Morepen Laboratories Forward Dividend Yield % Related Terms


NSE:MOREPENLAB vs ZTS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's Forward Dividend Yield % falls into.


NSE:MOREPENLAB
74GF Score
Morepen Laboratories Ltd NSE:MOREPENLAB
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morepen Laboratories Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Morepen Laboratories Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 0.2000002025-08-292025-08-310000-00-00Cash DividendannuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Morepen Laboratories's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=/53.16
=0.00 %

Current Share Price is ₹53.16.
Morepen Laboratories's Dividends per Share for the forward twelve months is calculated as * = .

Morepen Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.2/53.16
=0.38 %

Current Share Price is ₹53.16.
Morepen Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹0.2.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.38% mean?
Morepen Laboratories (NSE:MOREPENLAB) has a Forward Dividend Yield % of 0.38% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Morepen Laboratories and its competitors. According to the industry distribution chart, Morepen Laboratories ranks #440 out of 504 companies in the Drug Manufacturers industry, placing it in the top 87.3%.
Is Morepen Laboratories' Forward Dividend Yield % too high?
Morepen Laboratories' current Forward Dividend Yield % is 0.38%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. Morepen Laboratories' value of 0.38% is 81.7% below this industry median. Based on the distribution chart, Morepen Laboratories ranks #440 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Morepen Laboratories has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Morepen Laboratories ranks #440 out of 504 companies for Forward Dividend Yield %. This places Morepen Laboratories in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. Morepen Laboratories' value of 0.38% is 81.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Morepen Laboratories's current Forward Dividend Yield % of 0.38% is 81.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Morepen Laboratories and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Morepen Laboratories's current Forward Dividend Yield % is 0.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹49.82, compared to a current price of ₹53.16 — trading 6.7% above its estimated fair value. The current Forward Dividend Yield % is 0.38% and 81.7% below the Drug Manufacturers industry median of 2.08. Morepen Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Forward Dividend Yield % is 0.38% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued. The current stock price of ₹53.16 is trading 6.7% above its estimated GF Value™ of ₹49.82. GuruFocus considers Morepen Laboratories to be Fairly Valued.

Key valuation signals for NSE:MOREPENLAB:

  • Forward Dividend Yield %: 0.38%
  • GF Value™: ₹49.82 vs. price of ₹53.16 (6.7% above fair value)
  • GF Score™: 74/100 with 5 warning signs
  • Industry Position: 81.7% below the Drug Manufacturers median (#440 of 504)

No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Morepen Laboratories Business Description

Other Exchanges 500288:India
Address Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
74GF Score

Get the complete analysis for NSE:MOREPENLAB

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹53.16
Price
₹49.82
GF Value